Entrectinib treatment induces a durable response against <i>ARHGEF11::NTRK1</i> fusion gene‐positive spinal cord diffuse pediatric‐type high‐grade glioma-Reference-Cited by-同舟云学术

Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene‐positive spinal cord diffuse pediatric‐type high‐grade glioma

Published:2023-07 Issue:10 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Miyachi Mitsuru¹,Sugimoto Yohei¹,Sugitatsu Yuya¹,Tomida Akimasa¹,Yoshida Hideki¹,Tsuchiya Kunihiko¹,Umebayashi Daisuke²,Yamanaka Takumi²,Hashimoto Naoya²,Shishido‐Hara Yukiko³,Konishi Eiichi⁴,Iehara Tomoko¹^ORCID

Affiliation:

1. Department of Pediatrics Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

2. Department of Neurosurgery Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

3. Department of Pathology and Applied Neurobiology Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

4. Department of Surgical Pathology Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30513

Reference8 articles.

1. Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein

2. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

3. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

4. Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib

5. Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entrectinib/Temozolomide;Reactions Weekly;2024-07-13